↓ Skip to main content

Rutosides for treatment of post-thrombotic syndrome

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rutosides for treatment of post-thrombotic syndrome
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd005625.pub2
Pubmed ID
Authors

Morling JR, Yeoh SE, Kolbach DN

Abstract

Post-thrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT) that is characterised by pain, swelling, and skin changes in the affected limb. One in three patients with DVT will develop post-thrombotic sequelae within five years. Rutosides are a group of compounds derived from horse chestnut (Aesculus hippocastanum), a traditional herbal remedy for treating oedema formation in chronic venous insufficiency (CVI). However, it is not known whether rutosides are effective and safe in the treatment of PTS.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 44 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 18%
Other 8 18%
Researcher 5 11%
Student > Ph. D. Student 4 9%
Student > Postgraduate 3 7%
Other 11 24%
Unknown 6 13%
Readers by discipline Count As %
Medicine and Dentistry 24 53%
Nursing and Health Professions 5 11%
Agricultural and Biological Sciences 2 4%
Chemical Engineering 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 7 16%
Unknown 5 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2013.
All research outputs
#18,338,946
of 22,710,079 outputs
Outputs from Cochrane database of systematic reviews
#11,425
of 12,312 outputs
Outputs of similar age
#144,927
of 192,813 outputs
Outputs of similar age from Cochrane database of systematic reviews
#241
of 259 outputs
Altmetric has tracked 22,710,079 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,312 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,813 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 259 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.